Dr. Sabarina Ramanathan, M.D.
What this data tells you about Dr. Ramanathan
Dr. Sabarina Ramanathan is an internal medicine specialist in Sugar Land, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Ramanathan performed 12,197 Medicare services across 705 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramanathan received a total of $856 from 13 pharmaceutical and/or device companies across 20 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramanathan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 5,850 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 3,300 | $0 | $3 |
| Dexamethasone injection (steroid) | 900 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $114 |
| Blood draw (venipuncture) | 228 | $8 | $20 |
| Complete blood count (CBC) with differential | 216 | $8 | $36 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 151 | $19 | $157 |
| Injection, zoledronic acid, 1 mg | 134 | $6 | $431 |
| Administration of chemotherapy into vein, 1 hour or less | 131 | $92 | $707 |
| Office visit, established patient (20-29 min) | 96 | $64 | $250 |
| Injection of additional new drug or substance into vein | 89 | $11 | $108 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 72 | $267 | $2,762 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 68 | $46 | $313 |
| Office visit, established patient (30-39 min) | 66 | $91 | $368 |
| Hospital follow-up visit, moderate complexity | 55 | $61 | $247 |
| Injection, diphenhydramine hcl, up to 50 mg | 41 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 38 | $47 | $344 |
| Ct scan of chest with contrast | 32 | $41 | $821 |
| Drug injection, under skin or into muscle | 31 | $10 | $96 |
| Administration of chemotherapy into vein, each additional hour | 29 | $15 | $161 |
| CT scan of abdomen and pelvis with contrast | 28 | $131 | $1,067 |
| Comprehensive metabolic blood panel | 26 | $10 | $64 |
| Initial hospital admission, moderate complexity | 26 | $101 | $470 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Irrigation of implanted venous access drug delivery device | 20 | $16 | $114 |
| Red blood count automated, with additional calculations | 19 | $5 | $26 |
| New patient office visit (45-59 min) | 19 | $124 | $565 |
| Office visit, established patient, complex (40-54 min) | 18 | $124 | $496 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ramanathan is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ramanathan experienced with anti-nausea injection (fosaprepitant)?
Does Dr. Ramanathan receive payments from pharmaceutical companies?
How do Dr. Ramanathan's costs compare to other internal medicine physicians in Sugar Land?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology